New and slightly altered session formats break new ground in the first-time hybrid congress, taking place June 1-4 in Copenhagen, Denmark, and virtually.
In the phase 2 trial, skin biopsies before and after treatment showed significant reductions in inflammatory cytokines relevant to dermatomyositis pathogenesis.